S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
OTCMKTS:CSLLY

CSL (CSLLY) Stock Forecast, Price & News

$102.46
+0.18 (+0.18%)
(As of 06/2/2023 ET)
Compare
Today's Range
$102.15
$102.70
50-Day Range
$94.84
$103.28
52-Week Range
$83.30
$110.25
Volume
21,776 shs
Average Volume
27,212 shs
Market Capitalization
$98.85 billion
P/E Ratio
N/A
Dividend Yield
0.95%
Price Target
N/A

CSL MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.43mentions of CSL in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
26.57%
From $2.71 to $3.43 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.49 out of 5 stars


CSLLY stock logo

About CSL (OTCMKTS:CSLLY) Stock

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring and CSL Seqirus. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The CSL Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.

Receive CSLLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSLLY Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
CSL Limited (OTCMKTS:CSLLY) Short Interest Update
2023 Life Sciences Awards: CSL Seqirus
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
CSL January 2024 Options Begin Trading
See More Headlines

CSLLY Price History

CSLLY Company Calendar

Today
6/03/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CSLLY
Employees
30,000
Year Founded
1904

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.56 billion
Cash Flow
$3.04 per share
Book Value
$15.13 per share

Miscellaneous

Free Float
N/A
Market Cap
$98.85 billion
Optionable
Not Optionable
Beta
0.70

Key Executives

  • Paul McKenzie
    Chief Executive Officer, MD & Director
  • Joy Carolyn Linton
    Chief Financial Officer
  • Andrew Nash
    Chief Scientific Officer, SVP & Head-Research
  • William Mezzanotte
    CMO, Executive VP, Head-Research & Development
  • Bill Campbell
    Chief Commercial Officer & Executive VP













CSLLY Stock - Frequently Asked Questions

Should I buy or sell CSL stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CSL in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CSLLY shares.
View CSLLY analyst ratings
or view top-rated stocks.

How have CSLLY shares performed in 2023?

CSL's stock was trading at $97.54 on January 1st, 2023. Since then, CSLLY shares have increased by 5.0% and is now trading at $102.46.
View the best growth stocks for 2023 here
.

Are investors shorting CSL?

CSL saw a increase in short interest in May. As of May 15th, there was short interest totaling 18,600 shares, an increase of 18,500.0% from the April 30th total of 100 shares. Based on an average daily trading volume, of 50,200 shares, the short-interest ratio is currently 0.4 days.
View CSL's Short Interest
.

Is CSL a good dividend stock?

CSL (OTCMKTS:CSLLY) pays an annual dividend of $0.97 per share and currently has a dividend yield of 0.95%.
Read our dividend analysis for CSLLY.

What is CSL's stock symbol?

CSL trades on the OTCMKTS under the ticker symbol "CSLLY."

How do I buy shares of CSL?

Shares of CSLLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CSL's stock price today?

One share of CSLLY stock can currently be purchased for approximately $102.46.

How much money does CSL make?

CSL (OTCMKTS:CSLLY) has a market capitalization of $98.85 billion and generates $10.56 billion in revenue each year.

How many employees does CSL have?

The company employs 30,000 workers across the globe.

How can I contact CSL?

CSL's mailing address is 45 Poplar Road, Parkville C3, 3052. The official website for the company is www.csl.com.au. The company can be reached via phone at (139) 389-1911, via email at bernard.ronchi@csl.com, or via fax at 61-3-9389-1434.

This page (OTCMKTS:CSLLY) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -